Scripps VIVO

Academic Article RDF

• 153
• 154
• 155
• 156
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• 168
• 169
• 170
• 171
• 172
• 173
• 174
• 175
• 176
• 177
• 178
• 179
• 180
• 181
• 182
• 183
• 184
• 185
• 186
• 187
• 188
• 189
• 190
• 191
• 192
• 193
• more...

• Antibody-targeted interleukin-2 stimulates t-cell killing of autologous tumor-cells
• Anticancer properties of distinct antimalarial drug classes
• Anticholinergic potency of psychoactive drugs in human and rat cerebral cortex and striatum
• Anticipatory 50 kHz ultrasonic vocalizations are associated with escalated alcohol intake in dependent rats
• Anticipatory active-site motions and chromophore distortion prime photoreceptor PYP for light activation
• Anticoagulant dysfunction of human Arg352Trp-activated protein C caused by defective factor Va inactivation
• Anticoagulant protein-C pathway defective in majority of thrombophilic patients
• Anticoagulant response to activated protein-C- method validation and assay comparison
• Anticoagulant responses to thrombin are enhanced during regression of atherosclerosis in monkeys
• Anticoagulant synergism of heparin and activated protein C in vitro - role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C
• Anticodon G recognition by tRNA synthetases mimics the tRNA core
• Anticolon cancer activity of largazole, a marine-derived tunable histone deacetylase inhibitor
• Anticonvulsant activity of a nonpeptide galanin receptor agonist
• Anticytokine gene therapy of autoimmune diseases
• Anticytoplasmic antibodies in antinuclear antibody-negative lupus erythematosus. Correlation with clinical course
• Antidepressant-like effects of albizzia julibrissin in mice: Involvement of the 5-ht1a receptor system
• Antidepressants influence somatostatin levels and receptor pharmacology in brain
• Antidepressants modulate the CNS effects of corticotropin releasing-factor in rats
• Antidiabetic action of a liver x receptor agonist mediated by inhibition of hepatic gluconeogenesis
• Antidiabetic actions of a non-agonist PPARγ ligand blocking Cdk5-mediated phosphorylation
• Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist
• Antidiabetic phospholipid-nuclear receptor complex reveals the mechanism for phospholipid-driven gene regulation
• Antifungal activities of recombinant antifungal protein by conjugation with polyethylene glycol
• Antifungal azoles: structural insights into undesired tight binding to cholesterol-metabolizing CYP46A1
• Antifungal imidazoles block assembly of inducible no synthase into an active dimer
• Antifungal mechanism of a cysteine-rich antimicrobial peptide, ib-amp1, from impatiens balsamina against candida albicans
• Antigen compartmentation and t helper cell tolerance induction
• Antigen concentration and precursor frequency determine the rate of CD8+ T cell tolerance to peripherally expressed antigens
• Antigen delivery to macrophages using liposomal nanoparticles targeting sialoadhesin/cd169
• Antigen presentation and cytotoxic t-lymphocyte killing studied in individual, living cells

• 153
• 154
• 155
• 156
• 157
• 158
• 159
• 160
• 161
• 162
• 163
• 164
• 165
• 166
• 167
• 168
• 169
• 170
• 171
• 172
• 173
• 174
• 175
• 176
• 177
• 178
• 179
• 180
• 181
• 182
• 183
• 184
• 185
• 186
• 187
• 188
• 189
• 190
• 191
• 192
• 193
• more...